Hormonal therapy in advanced or recurrent endometrial cancer-Reference-Cited by-同舟云学术

Hormonal therapy in advanced or recurrent endometrial cancer

Published:2010-12-08 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Kokka Fani¹,Brockbank Elly²,Oram David²,Gallagher Chris³,Bryant Andrew⁴

Affiliation:

1. Queen Elizabeth The Queen Mother Hospital; Women's Health, Birchington Ward; St Peters Road Kent UK CT9 4AN

2. St. Bartholomew's Hospital; Department of Gynaecological Oncology; Barts and The London Trust West Smithfield London UK EC1A 7BE

3. St Bartholomew's Hospital; Medical Oncology; Barts and The London Trust West Smithfield London UK EC1A 7BE

4. Newcastle University; Institute of Health & Society; Medical School New Build Richardson Road Newcastle upon Tyne UK NE2 4AX

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD007926.pub2/fullpdf

Reference91 articles.

1. Efficacy of sequential cyclical hormonal therapy in endometrial cancer and its correlation with steroid hormone receptor status;Ayoub;Gynecologic Oncology,1988

2. Pandya KJ Yeap B Y Weiner LM Krook JE Erban JK Schinella RA Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882) American Journal of Clinical Oncology 2001 43 6

3. Rendina GM Donadio C Fabri M Mazzoni P Nazzicone P Tamoxifen and medroxyprogesterone therapy for advanced endometrial carcinoma European Journal of Obstetrics, Gynecology, and Reproductive Biology 1984 285 91

4. Stolyarova I Minaev A Effect of hormonotherapy on the results of radiation treatment in patients with endometrial carcinoma Journal of B.U.On 2001 271 4

5. Thigpen JT Brady MF Alvarez RD Adelson MD Homesley HD Manetta A Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group Journal of Clinical Oncology 1999 1736 44

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

2. Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial Carcinoma;Cancers;2024-05-30

3. High-Grade Endometrial Cancer: Molecular Subtypes, Current Challenges, and Treatment Options;Reproductive Sciences;2024-04-24

4. Redefining the Position of Hormonal Therapy in Endometrial Cancer in the Era of Molecular Classification;Journal of Clinical Oncology;2024-01-01

5. Androgen receptor and its correlation with estrogen and progesterone receptors, aimed for identification of cases for future anti-androgen therapy in endometrial cancers;PLOS ONE;2023-09-19